Drug Type iNKT cell therapy |
Synonyms natural killer T cell(Tsinghua University) |
Target- |
Mechanism Immunologic cytotoxicity, Natural killer cell replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Phase 2 | CN | 01 Nov 2015 | |
Colorectal Cancer | Phase 2 | CN | 01 Nov 2015 | |
Colorectal Cancer | Phase 2 | CN | 01 Nov 2015 | |
Hepatocellular Carcinoma | Phase 2 | CN | 01 Nov 2015 | |
Hepatocellular Carcinoma | Phase 2 | CN | 01 Nov 2015 | |
Hepatocellular Carcinoma | Phase 2 | CN | 01 Nov 2015 | |
Non-Small Cell Lung Cancer | Phase 2 | CN | 01 Nov 2015 | |
Non-Small Cell Lung Cancer | Phase 2 | CN | 01 Nov 2015 | |
Non-Small Cell Lung Cancer | Phase 2 | CN | 01 Nov 2015 | |
Stomach Cancer | Phase 2 | CN | 01 Nov 2015 |